3 May 2011

Cimzia® (certolizumab pegol) data showed rapid improvement in signs and symptoms predicted better long-term outcomes in rheumatoid arthritis patients

Read More
28 Apr 2011

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
28 Apr 2011

UCB devient leader dans le domaine de la biopharmacie centrée sur le patient

Read More
28 Apr 2011

UCB wordt een patiëntgerichte biofarmaceutische leider

Read More
28 Apr 2011

UCB is becoming a patient-centric biopharma leader

Read More
28 Apr 2011

UCB - good start to achieve its 2011 financial outlook - Interim Report for the first quarter of 2011

Read More
28 Apr 2011

UCB – goed begin om de financiële vooruitzichten voor 2011 waar te maken - Interimverslag eerste kwartaal 2011

Read More
28 Apr 2011

UCB en bonne voie pour atteindre les perspectives financières 2011 - Rapport intermédiaire relatif au premier trimestre 2011

Read More
26 Apr 2011

Rheumatoid arthritis patients treated with Cimzia® (certolizumab pegol) reported clinically meaningful improvements in physical function, fatigue and pain and an associated increased productivity at work and within the home

Read More
21 Apr 2011

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
Subscribe to